可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Hylek EM , Skates SJ , Sheehan MA, et al. Analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation [J]. N Engl J Med , 1996,335: 540.
[2] The Stroke Prevention in Atrial Fibrillation Invenstigators. Predictors of thromboembolism in atrial fibrillation: Echocardiographic feature of patietns at risk [J]. Ann Intern Med , 1992, 116: 6.
[3] Mugge A, Kuhn H, Nikutta P, et al. Assessment of left atrial
appendage function by bip lane transesophageal echocardiography in patients with nonrheumatic atrial
fibrillation: Identification of a subgroup of patients at increased embolic risk [J]. J Am Coll Cardiol, 1994, 23: 599.
[4] Atrial Fibrillation Investigators. Risk factors for stroke and
efficacy of antith romboembolism therapy in atrial fibrillation analysis of pooled data from five randomized controlled trials [J]. Arch Intern Med, 1994, 154: 1449.
[5] Bath PMW , Prasad A , Bromn MM , et al. Survey of use of anticoagulation in patients with atrial fibrillation[J]. Br Med J ,1993, 307: 1492.
[6] Fatkin D, Kell RP, Feneley MP. Relation between left atrial
appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo [J]. J Am Coll Cardiol, 1994, 23: 961.
[7] Mugge A , Kuhn H, Daniel WG, et al. The role of
transesophageal echocardiography in the detection of left atrial thrombi[J]. Echocardiography, 1993, 10: 405.
[8] Schnittger I. Value of transesophageal echocardiography before DC cardioversion in patients with atrial fibrillation: A ssessment of embolic risk [J]. Br H eart J , 1995, 73: 306.